Clinical trial
A Limited Food Effect Study of 800 mg Gabapentin Tablets Versus 400 mg Gabapentin Capsules
NCT00865631 is registered in ClinicalTrials.gov with Actavis Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Limited Food Effect Study of 800 mg Gabapentin Tablets Versus 400 mg Gabapentin Capsules
- Lead sponsor
- Actavis Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 30, 1999
- Completion date
- June 30, 1999
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy